April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Role of MMPs in TNF--Induced Loss of Barrier Integrity of Corneal Endothelium
Author Affiliations & Notes
  • M. Shivanna
    Optometry, Indiana Univ Sch of Optometry, Bloomington, Indiana
  • M. Satpathy
    Hematology/Oncology, IUPUI, Indianapolis, Indiana
  • S. P. Srinivas
    Optometry, Indiana Univ Sch of Optometry, Bloomington, Indiana
  • Footnotes
    Commercial Relationships  M. Shivanna, None; M. Satpathy, None; S.P. Srinivas, None.
  • Footnotes
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1815. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Shivanna, M. Satpathy, S. P. Srinivas; Role of MMPs in TNF--Induced Loss of Barrier Integrity of Corneal Endothelium. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1815.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : TNF- is a pleiotropic cytokine implicated in corneal endothelial failure during allograft rejection. In this study, we have investigated the role of matrix metalloproteinases (MMPs) in the TNF--induced loss of barrier integrity in cultured bovine corneal endothelial cells (BCEC).

Methods: : Changes in the barrier integrity were assessed in terms of trans-endothelial electrical resistance (TER) obtained from electrical cell-substrate impedance sensing (ECISTM, Applied Biophysics, Inc, NY). Apical junctional assembly was visualized by immunolocalization of cadherins (with a pan-cadherin a/b) and ZO-1. MMP activity in the conditioned media from cells treated with TNF- was visualized by gelatin zymography.

Results: : Exposure to TNF- (20 ng/ml; 6 hr) induced dispersion of ZO-1 and cadherins and also led to loss of peri-junctional actomyosin ring. TNF- also caused a decline in TER, which sustained for more than 20 hr. These effects were opposed by pre-treatment with GM-6001 (a broad spectrum MMP inhibitor; 50 µM; 1 hr) and minocycline (50 µg/ml; 1 hr), a selective MMP-2 and MMP-9 inhibitor. Pronounced inhibition of the loss in TER was also noticed upon pretreatment with a selective p38 MAPK inhibitor, SB-203580. An increase in MMP-9 activity in the conditioned media was observed upon exposure to TNF- for 20 hr.

Keywords: cornea: endothelium • cytokines/chemokines • pump/barrier function 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.